Skye Bioscience, Inc. Convertible Debt, Noncurrent
Skye Bioscience, Inc. (SKYE) had Convertible Debt, Noncurrent of $0 as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2022-03-28
- 2021-12-31: Convertible Debt, Noncurrent $0.00.
- 2021-09-30: Convertible Debt, Noncurrent $1.37M.
- 2021-06-30: Convertible Debt, Noncurrent $1.22M.
- 2021-03-31: Convertible Debt, Noncurrent $1.07M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-28 |
| 2021-09-30 | $1.37M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.22M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.07M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $931.10K 10-K · filed 2022-03-28 |
| 2020-09-30 | $789.69K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $651.46K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $517.78K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $387.07K 10-K · filed 2021-03-02 |
| 2019-09-30 | $3.30M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.10M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.91M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.36M 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |